Compare Medtronic PLC (MDT) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs PepsiCo, Inc. — how do they compare? Medtronic PLC trades at $82.53 (market cap $106.61B), while PepsiCo, Inc. trades at $134.56 (market cap $184.89B). The key difference: PepsiCo, Inc. is the larger of the two by market cap, and PepsiCo, Inc. pays the higher dividend (4.37%). Which is the better fit depends on your goals.
| MDT | PEP | |
|---|---|---|
Market Cap | $106.61B | $184.89B |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $170.44 |
52-Week Low | $73.75 | $135.40 |
Enterprise Value | $125.36B | $227.39B |
Dividend Yield | 3.46% | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
PepsiCo (PEP) trades at $134.62, down 1.82% over the past day, with a bearish technical signal from moving averages. The company reported revenue of $93.93B in 2025, with a net income margin of 10.78% and a P/E ratio of 17.75. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while Q3 2026 earnings are anticipated at $2.32 EPS. Analyst consensus is a 'Hold' with a $158.50 price target, suggesting moderate upside from current levels.
The outlook for PEP hinges on execution of its North American turnaround and margin expansion initiatives. Risks include competitive pressures and sensitivity to consumer spending. With strong cash flow generation and a dividend yield near 4%, the stock offers value for income-focused investors, though near-term volatility may persist amid earnings uncertainty and market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
